He entered medical school with the goal to combine basic science, medical device technology, and clinical Cardiovascular practice. He holds undergraduate and graduate degrees in Physics, Electrical Engineering, and Biomedical Engineering. He is driven by a lifelong passion of understanding how things work and developing new technologies for medical application.
Schwartz grew up in Boulder, Colorado, enjoying and thriving in the academic community surrounding the University of Colorado. He holds a Bachelor’s Degree from the University of Alabama. He served as a Director of Biomerix Corporation. He serves as a Director of Zift Medical, LLC. He serves as a Board Member of NeuralAnalytics and the Discovery Science Center in Orange County. Rowe also serves as Director of Remon Medical Ltd. He serves as a Director of InSeal Medical Ltd. Rowe joined Cordis after having held several positions in product management for various medical device companies. At JJIS and the related Cordis Corporation, he held a variety of positions with increasing levels of responsibility, including heading Johnson & Johnson’s Business Development, Advanced Technology, Worldwide Clinical Research and Marketing groups. Rowe served as a Vice President of Business Development at Johnson & Johnson’s Interventional Systems Division (JJIS), responsible for Johnson & Johnson’s coronary stent development efforts. He served as the Corporate Vice President of Business Development and Strategic Planning at Datascope Corp.
Rowe served as the President and Chief Executive Officer of Percutaneous Valve Technologies Inc. He Founded Percutaneous Valve Technologies (sold to Edwards). Rowe served as a Scientific Advisor at Ascent Biomedical Ventures. since 2008 and serves as its Corporate Vice President of Advanced Technology. Rowe, also known as Stan, now CEO of the NXT Biomedical Incubator has been the Chief Scientific Officer of Edwards Lifesciences Corp. Meet the minds behind this platform for innovation. It takes a lifetime of experimentation, study of medical literature and procedures, and investment in novel solutions to equip a team capable of developing breakthrough ideas into promising commercial products. The ambitions of NTX Biomedical are born in these committed medical device innovators. NXT has already started investing in intellectual property, and seeks to output biomedical startups as we complete early feasibility. The idea is to develop breakthrough technologies no matter where they come from geographically.
0 kommentar(er)
